RICCIERI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 7.892
EU - Europa 2.093
AS - Asia 1.461
SA - Sud America 75
AF - Africa 41
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.566
Nazione #
US - Stati Uniti d'America 7.838
IT - Italia 720
SG - Singapore 560
CN - Cina 414
IN - India 414
SE - Svezia 382
UA - Ucraina 274
FI - Finlandia 257
DE - Germania 131
GB - Regno Unito 68
AR - Argentina 56
CA - Canada 47
IE - Irlanda 42
RO - Romania 40
ID - Indonesia 33
FR - Francia 32
BG - Bulgaria 31
TG - Togo 27
RU - Federazione Russa 26
AT - Austria 20
BE - Belgio 17
NL - Olanda 13
ZA - Sudafrica 9
CH - Svizzera 8
TR - Turchia 8
PL - Polonia 7
CO - Colombia 6
HK - Hong Kong 6
KR - Corea 6
MK - Macedonia 6
CL - Cile 5
BR - Brasile 4
MX - Messico 4
PE - Perù 4
AU - Australia 3
ES - Italia 3
JP - Giappone 3
MY - Malesia 3
RS - Serbia 3
SC - Seychelles 3
AL - Albania 2
BZ - Belize 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
PH - Filippine 2
SA - Arabia Saudita 2
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 11.566
Città #
Fairfield 1.232
Woodbridge 624
Chandler 619
Ashburn 597
Seattle 467
Houston 419
Singapore 388
Cambridge 387
Wilmington 366
Princeton 265
Beijing 244
Rome 233
Ann Arbor 232
Plano 188
San Paolo di Civitate 188
Santa Clara 188
Dearborn 183
Lawrence 169
Boston 128
Jacksonville 115
San Diego 114
Millbury 97
Helsinki 84
Andover 68
Fremont 62
Federal 56
New York 50
Des Moines 49
Norwalk 44
Boardman 43
Dublin 39
Toronto 34
Jakarta 32
Sofia 31
San Mateo 28
Lomé 27
Falls Church 25
Bremen 21
Nanjing 21
Mannheim 20
Falkenstein 19
Milan 18
Brussels 17
Stockholm 16
Vienna 16
Bühl 15
Moscow 14
Pune 14
Palermo 12
Kunming 11
London 11
Phoenix 10
Southend 10
Buffalo 9
Fasano 9
Guangzhou 9
Indiana 9
Redwood City 9
Los Angeles 8
Monterotondo 8
Ottawa 8
Frankfurt am Main 7
Istanbul 7
Reggio Calabria 7
Bogotá 6
Craiova 6
Jinan 6
Changsha 5
Hefei 5
Muizenberg 5
Naples 5
Redmond 5
Shanghai 5
Shenyang 5
Treviso 5
Bari 4
Florence 4
Gdansk 4
Lappeenranta 4
Modena 4
Montréal 4
Zhengzhou 4
Amsterdam 3
Bern 3
Catania 3
Edinburgh 3
Farra di Soligo 3
Fort Worth 3
Frosinone 3
Fuzhou 3
Hebei 3
Hong Kong 3
Ilsan 3
Marietta 3
Mexico City 3
Munich 3
Paris 3
Pescara 3
Provo 3
San Jose 3
Totale 8.590
Nome #
Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement 112
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 111
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 111
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients 105
Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. 101
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 100
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 98
Anti-carbonic anhydrase II antibodies in systemic sclerosis: Association with lung involvement 93
LUPUS-ERYTHEMATOSUS PANNICULITIS - AN IMMUNOHISTOCHEMICAL STUDY 93
Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy 91
Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients 85
Potential role for the VDR agonist elocalcitol in metabolic control: evidences in human skeletal muscle cells 85
Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al. 85
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database 83
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study 83
Anti-endothelial cell antibodies in rheumatic heart disease 83
Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus 81
Comparison of ultrasound transmission velocity with computed metacarpal radiogrammetry and dual-photon absorptiometry 81
[Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis]. 79
Correlazioni dell’età e della durata di menopausa con la velocità di trasmissione degli ultrasuoni (VTU) e con la mineralometria lombare. 78
Adhesion molecule expression in the synovial membrane of psoriatic arthritis 77
Update of EULAR recommendations for the treatment of systemic sclerosis 77
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. 77
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 77
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 77
Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome 77
LONG-TERM FOLLOW-UP OF LOW-DOSE METHOTREXATE THERAPY IN ONE CASE OF IDIOPATHIC RETROPERITONEAL FIBROSIS 76
The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature 76
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 75
"In sickness and in health": the peculiar occurrence of polymyalgia rheumatica in married cohabiting couples-a case series and review of the literature. 75
Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis 74
Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement 74
High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy 73
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. 73
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities 73
Successful Immunosuppressive Treatment of Dermatomyositis: A Nailfold Capillaroscopy Survey 72
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 72
Autonomic dysfunction and microvascular damage in systemic sclerosis. 72
Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis 71
Digital ulcers predict a worse disease course in patients with systemic sclerosis 71
Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study 71
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 71
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile 71
Ultrasound Elastography Assessment of Skin Involvement in Systemic Sclerosis: Lights and Shadows 69
Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis 69
STERNOCLAVICULAR JOINT DISEASE IN PSORIATIC-ARTHRITIS 69
Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A 67
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus 67
A CASE OF RELAPSING POLYCHONDRITIS - PATHOGENETIC CONSIDERATIONS 67
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study 67
Retroperitoneal fibrosis: a case of a patient (63y/o) treated with low-dose methotrexate (MTX) and 6-methylprednisolone (6-MP) 67
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study 67
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases 66
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal 66
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 66
Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis. analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening 66
Association of a KCNA5 Gene Polymorphism With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in the European Caucasian Population 65
Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization 65
IL RAPPORTO DEIDROEPIANDROSTERONE-SOLFATO/CORTISOLO NELL'ARTRITE REUMATOIDE:CORRELAZIONI CON L'INTERLEUKINA-6 64
Soluble interleukin-2 receptor and interleukin-6 levels: Evaluation during cyclosporin a and methotrexate treatment in psoriatic arthritis 64
Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus 64
ONE-YEAR TREATMENT WITH LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS - EFFECT ON CLASS-SPECIFIC RHEUMATOID FACTORS 64
Parameters of oxidative stress status in healthy subjects: Their correlations and stability after sample collection 62
Fetal programming and systemic sclerosis 62
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group 62
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica 62
The antimicrobial peptide LL37 is a T cell autoantigen in psoriasis 61
Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis 61
Co-occurrence of psoriatic arthritis with collagenous colitis: Clinicopathologic findings of a case 61
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 61
Changes of glycosylation of serum proteins in Sjogren's syndrome: Correlation with interleukin-6 and soluble interleukin-2 receptor 61
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population 60
The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies 60
ULTRASOUND TRANSMISSION VELOCITY OF THE PROXIMAL PHALANXES OF THE NON DOMINANT HAND IN THE STUDY OF OSTEOPOROSIS 60
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists 60
Soluble interleukin-2 receptor in Sjogren's syndrome: Relation to main serum immunological and immunohistochemical parameters 60
Treatment of Wegener's granulomatosis 60
Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis 59
Nedd5, a novel autoantigen in systemic sclerosis: is it a marker of more severe disease? 59
Brief report: Candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity 59
Oxidative stress parameters in different systemic rheumatic diseases 59
Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis 59
Association of circulating cxcl10 and cxcl11 with systemic sclerosis 59
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis 59
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 58
The role of interleukin-12 in immune-mediated rheumatic diseases 58
Down-regulation of cytotoxic expression on peripheral blood mononuclear cells in patiens with primary Sjogren's syndrome 57
Treatment Algorithms for Systemic Sclerosis According to Experts 57
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 57
Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor 57
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis. 57
To Be or Not To Be," Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity 57
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: A eustar case-control study 57
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis 56
Stabilization of microcirculation in patients with early systemic sclerosis with diffuse skin involvement following rituximab treatment: An open-label study 56
Complementary effects of carbamylated and citrullinated ll37 in autoimmunity and inflammation in systemic lupus erythematosus 56
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus 56
Case definition of psoriatic arthritis 55
Gender Disparity in Susceptibility to Oxidative Stress and Apoptosis Induced by Autoantibodies Specific to RLIP76 in Vascular Cells 55
Analisi immunoistochimica dell'espressione delle principali molecole di adesione e dei fattori di necrosi tumorale a livello della membrana sinoviale nell'artrite psoriasica 54
Totale 7.028
Categoria #
all - tutte 41.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.738 0 0 0 0 0 359 340 273 252 306 145 63
2020/2021992 91 103 40 57 36 104 15 99 119 180 103 45
2021/20222.428 8 140 244 101 288 94 68 219 178 203 396 489
2022/20232.266 490 551 110 256 230 218 27 106 168 26 53 31
2023/20241.045 74 133 35 63 67 121 64 112 21 129 105 121
2024/2025957 113 110 144 164 198 228 0 0 0 0 0 0
Totale 12.073